| Name | 2-(((tert-Butyldimethylsilyl)oxy)methyl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline |
|---|---|
| Synonyms | 2-[[tert-butyl(dimethyl)silyl]oxymethyl]-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline |
| Molecular Formula | C19H34BNO3Si |
|---|---|
| Molecular Weight | 363.37500 |
| Exact Mass | 363.24000 |
| PSA | 53.71000 |
| LogP | 4.67100 |
| HS Code | 2934999090 |
|---|
|
~%
1147531-06-3 |
| Literature: Roche Palo Alto LLC Patent: US2009/105209 A1, 2009 ; Location in patent: Page/Page column 62 ; US 20090105209 A1 |
| Precursor 1 | |
|---|---|
| DownStream 0 | |
| HS Code | 2934999090 |
|---|---|
| Summary | 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |